Neurotech International Ltd

Research Neurotech International Ltd (NTI) on Bullrun: market cap AUD 18.45M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNTI
• ExchangeAU
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyAUD
• Market capAUD 18.45M
• Financial periodFY2025
• RevenueAUD 238
• Revenue growth-87.9%
• Net income-AUD 10.60M
• Free cash flow-AUD 9.02M
• Gross margin100.0%

Valuation Snapshot

latest market cap is AUD 18.45M.

About Neurotech International Ltd

Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company focuses on development and commercialization of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxation in autistic children exhibiting elevated delta band brain activity.

Frequently asked questions

What is Neurotech International Ltd's market cap?

Neurotech International Ltd's market capitalization is AUD 18.45M.

What does Neurotech International Ltd do?

Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia.